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Background: Electro-physical agents (EPAs) are fundamental components in the management arsenal of physiotherapy.
The objective of this study was to provide a comprehensive understanding of the factors affecting the decisions made by
Physiotherapists (PTs) when choosing to apply EPAs as a treatment modality.
Methods: A purpose-designed questionnaire was developed to investigate the contribution of 13 factors on the
decision to use EPAs. Two hundred questionnaires were randomly distributed to PTs attending the annual conference
of the Israeli Physiotherapy Society, 2014. The factors were grouped into six categories and Wilcoxon Sign Rank tests
were applied to compare their impact on decision making.
Results: In total, 144 (72%) questionnaires were completed. Good internal consistency was found for the 13 component of
the decisions factors (Cronbach’s coefficient alpha = 0.77) with unequal distribution of answers in each question (p < 0.01).
Eighty-one percent of the participants reported past experience, and 55 % mentioned research evidence as
strong or very strong factors which influence their decision to use of EPAs. However, only 38% of the participants
reported patients’ preferences as a strong or very strong factor. Comparisons between the six categories of the
decision factors determined three levels of impact (rank scores) which were significantly different from each
other (p < 0.01). Availability of equipment ranked the highest. The lowest level of impact included two categories,
technology related issues and patients’ and physicians’ preferences.
Conclusion: The participating PTs were likely to make decisions which were strongly impacted by availability of
equipment and operational factors. This research can be used to provide practicing PTs with a basis for a critical
appraisal of their decision making regarding the application of EAPs. In addition, due to the strong impact of
availability of equipment, health policy makers should verify that the available equipment is up to date with the
best research evidence.
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Electro-physical agents (EPAs) are fundamental compo-
nents in the management arsenal of physiotherapists
(PTs), used primarily as adjunct modalities with other
forms of treatment. Utilizing different energy forms, EPAs
are applied for diagnostic, therapeutic, and feedback pur-
poses [1,2]. However, choosing the beneficial EPA and the
most appropriate technique and dosage, are often not
simple clinical decisions, bearing in mind that when used
inappropriately, EPAs may not only be ineffective, but
may have a detrimental effect on a patient’s wellbeing [3].* Correspondence: shmuels@ariel.ac.il
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unless otherwise stated.There is growing research interest in the clinical
decision-making skills of health professionals in general,
including PTs [4-10]. Addressing decision-making in re-
gard to EPAs, Watson [11] proposed a comprehensive
model that includes: identification of the patient’s prob-
lems, leading to the establishment of therapeutic goals
and priorities; determination of the physiological mecha-
nisms which need to be activated or enhanced; and then
selecting the treatment method and dosage which is
expected to activate these mechanisms based on the best
available evidence. Other factors, in addition to research
evidence, that may influence the choice of which EPAs to
use include clinical expertise, patient preferences [5,7],
and availability of equipment [12].l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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use and the availability of equipment [13-16]. However,
most reports did not address the factors affecting the
PTs decision as to when and how to use the EPAs. In an
early study regarding the frequency and availability of
EPAs, Robinson and Snyder-Mackler [12] also purported
to identify factors that affect how and when EPAs are used.
However, they only evaluated the availability of equipment
and the adequacy of education in clinical electrotherapy,
indicating that both these factors significantly affect the
frequency of EPA application. Lindsay et al. [17], address-
ing PTs working at private clinics, reported that the most
common reasons for choosing specific modalities are ef-
fectiveness, familiarity, ease of application, cost, and safety.
However, as this was an early study, it did not consider sci-
entific evidence, referred only to the subjective experience
of the therapist, and only provided descriptive data without
statistical analysis of the significance of each factor.
More recently, Houghton et al. [3] published a comprehen-
sive guideline intended to provide a resource for clinical
decision-making regarding EPAs use. The authors indi-
cated that their motivation for developing this guideline
was the discrepancies between EPAs educators and course
participants in terms of what was considered safe practice
with respect to EPAs. Therefore, the focus of their guide-
line is restricted to contraindications and precautions and
does not address other critical components of decision-
making.
In light of the limited research on the factors that con-
tribute to decision-making regarding the application of
EPAs, the primary objective of this study was to provide a
more comprehensive understanding of the factors affecting
the decision to use an EPA. A better understanding of the
relative contribution of the factors playing a role in these
decisions might assist in determining the measures re-
quired to ensure the most appropriate application of EPAs.
Methods
Procedure
The study was approved by the Institutional Review Board
of the Faculty of Social Welfare and Health Sciences at the
University of Haifa, Haifa, Israel. A draft questionnaire
was developed by the researchers on the basis of previous
studies regarding the availability and frequency of EPAs
use and factors affecting the decision to use EPAs in prac-
tice [12-16]. Content validity of the questionnaire was ex-
amined through a rigorous, iterative process with physical
therapy faculty involved in EPA education, and with expe-
rienced practitioners. This was followed by a pilot test
with five PT clinicians who were requested to comment
whether the questionnaire items were clear and concise.
The final questionnaire included three main sections.
The first section included demographic characteristics of
the respondents and questions regarding the availabilityof equipment and frequency of use. The second section
included thirteen factors that may affect the respondent’s
decision to use EPAs (decision factors). The participants
were requested to note their responses on a five point
Likert scale, with 1 indicating no influence on decision
and 5 a very strong influence on decision. The last section
included questions related to indications for the use of
specific electrical stimulation current forms. This is not
reported in the present paper.
The survey was conducted during the annual confer-
ence of the Israeli Physical Therapy Society, 2014. Two
hundred questionnaires were randomly distributed to the
PTs attending the conference, who were asked to return
the completed questionnaire to the polling booth in the
conference hall.
Data analysis
Descriptive statistics included means, standard deviations,
percentages and frequencies, as appropriate. Cronbach’s co-
efficient alpha test was used to determine the internal
consistency of the 13 decision factors. Chi-Square tests for
equal proportions were used to examine the differences in
the distribution of answers in the decision factors section.
Bonferroni corrections were applied to account for multiple
comparisons. Consensus was reached by the researchers,
who are all expert PT clinicians (each with over 15 years of
clinical experience) and educators in the field of EPA, as to
the grouping of the decision factors into the following six
categories, as follows: (1) Background and experience
(items: entry level studies, continuing education, previous
clinical experience with EPA and demonstrations of new
equipment by medical marketers), (2) Research evidence
of efficacy, (3) Technology related issues (items: techno-
phobia, fear of adverse events). (4) Availability of equip-
ment, (5) Operational issues (items: time and ease of
application, degree of self-confidence in operating the de-
vice, and busy, tight schedule at workplace), and (6) Prefer-
ences (items: patient preference and physician prescription).
The Wilcoxon Sign Rank test with Bonferroni correc-
tions was applied to compare the degree of impact of each
category on the decision to use an EPA. Statistical analyses
were performed using SAS 9.3 and Excel (Microsoft Corp.,
Redmond, WA, USA).
Results
Among the 200 distributed questionnaires, 144 were
completed and returned, indicating a response rate of
72%.The respondents’ characteristics are presented in
Table 1. Mean age was 38.3 (±9.42) years, with almost equal
distribution between females and males. The majority
(98%) was clinical practitioners; with most (62.5%) defining
their area of practice as orthopedics and sports. Forty
percent of the PTs worked from 20 to 30 hours a week
and 51.4% worked more than 30 hours a week.
Table 1 Demographic characteristics of the study sample
(n = 144)
Characteristic Mean ± SD or Number (%)




Not indicated 1 (0.7)
Degree
Bachelors (entry level) 144 (100)
Advanced masters in PT 24 (16.7)
Masters in another area 15 (10.4)
Professional seniority, years 11.2 ± 9.9
Area of practice
Orthopedic and sports rehabilitation 90 (62.5)
Neurologic rehabilitation 29 (20.1)
Women’s health 3 (2.1)
Child development 3 (2.1)
Respiratory rehabilitation 5 (3.5)
Geriatric rehabilitation 10 (6.9)
Education 4 (2.8)
Hours worked per week
0-10 hours 13 (9.0)
21-30 hours 57 (39.6)
31-40 hours 41 (28.5)
>40 hours 33 (22.9)
Postgraduate courses in EPAs
Yes 62 (43.1)
No 81 (56.2)
Not indicated 1 (0.7)
EPAs- Electro-physical agents.
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pation in postgraduate courses regarding EPAs was noted
by 43.1% of the subjects.
Availability of 13 EPAs and their degree of usage is re-
ported in Table 2. The most frequently available agents
(≥80%) were transcutaneous electrical nerve stimulation
(TENS) (96.5%), heat packs (93.0%), ultrasound (US)
(92.3%), cold packs/ice (85.8%), interferential current
(IFC) (85.1%) and neuromuscular electrical stimulation
(80.0%). The only EPA that was reported as available to
50-79% of the respondents was a whirlpool bath (68.6%).
The less available EPAs (available to 30-49% of the respon-
dents) were shortwave (43.6%), biofeedback (36.0%) and
functional electrical stimulation (FES) (35.3%). The agents
that were available to less than 20% of the PTs were laser
(16.6%), shockwave (15.4%) and infrared (6.5%).The data on the usage of each EPA are presented in
Table 2. The most commonly used EPAs (defined as
used by at least 80% of the participants) were heat packs,
TENS, IFC and US (92.5%, 88.4%, 80.5%, and 80.3%, re-
spectively). In terms of frequency of use, heat packs were
used the most on a daily-week base (51.1%), followed by
electrical stimulation for sensory stimulation (IFC and
TENS at48.0% and 47.8%, respectively).
Good internal consistency was found for the thirteen
components of the decision factors (Cronbach’s coefficient
alpha = 0.77), Unequal distribution of answers to each ques-
tion was demonstrated (p < 0.01). The distribution of each
factor is reported in Table 3.Wilcoxon Sign Rank compari-
sons between the six categories of the decision factors de-
termined three levels of impact (rank scores) which were
significantly different from each other (p < 0.01) (see
Table 3). Availability of equipment (including only one
factor) ranked the highest. The second level of impact
included Background and experience, Research evidence
of efficacy, and Operational issues, with a total of 8 factors.
The lowest level of impact included: Technology-related
issues and Preferences, with a total of 4 factors.
Discussion
The findings regarding availability of EPAs and their fre-
quency of use reported by the respondents in the present
study are similar to results of previous studies. As in earlier
studies, the most commonly available and frequently used
agents were US, heat packs, cold packs/ice, and electrical
stimulation for sensory neuromodulation [13,14,18,19].
These findings indicate that the clinical utility of these
agents appears to be similar between different countries.
The primary aim of this study was to explore how vari-
ous factors influence PTs decision to use EPAs. Three
levels of impact on decision making were identified with
availability of equipment ranked as the most influential
factor and technology related issues and patient and phys-
ician preferences as the least influential. The findings sup-
port the growing understanding that clinical decision
making is a complex and multidimensional phenomenon
[5]. Therefore, raising awareness of factors that influence
decision making together with critical reflection upon the
nature of this influence may enhance the quality of clinical
decision making.
The evolution of clinical decision making in the physio-
therapy is parallel to the growth and maturation of the pro-
fession [20]. The ‘Evidence Based Practice’ approach, which
has been adopted by the physiotherapy profession as the
basis for optimizing and maximizing patient care, considers
research evidence, clinician expertise, and patient prefer-
ences as the key components in clinical decision making
[5,7]. Our findings indicate that PTs indeed consider two of
these three components as important factors that influence
their decision to use EPAs. Past experience was reported by
Table 2 Availability and use of Electro-physical agents (EPA)
EPA Availability % (frequency) Frequency of use: % (frequency)
Yes No Not sure Once a day Once a week Once a month Seldom Not at all
Biofeedback EMG 36.0 (49) 53.7 (73) 10.3 (14) 5.3 (5) 5.3 (5) 8.5 (8) 12.8 (12) 68.1 (64)
Cold packs/ice 85.8 (121) 9.9 (14) 4.3 (6) 20.2 (26) 20.9 (27) 14.7 (19) 19.4 (25) 24.8 (32)
FES 35.3 (49) 48.9 (68) 15.8 (22) 16.3 (15) 6.5 (6) 8.7 (8) 12.0 (11) 56.5 (52)
Heat packs 93.0 (133) 6.3 (9) 0.7 (1) 51.1 (68) 24.8 (33) 10.5 (14) 6.1 (8) 7.5 (10)
IFC 85.1 (120) 13.5 (19) 1.4 (2) 48.0 (59) 15.4 (19) 6.5 (8) 10.6 (13) 19.5 (24)
Infrared 6.5 (9) 86.2 (119) 7.3 (10) 5.6 (4) 1.4 (1) 0 (0) 12.7 (9) 80.3 (57)
Laser 16.6 (23) 74.8 (104) 8.6 (12) 6.2 (5) 3.7 (3) 2.5 (2) 11.3 (9) 76.3 (61)
NMES 80.0 (112) 14.3 (20) 5.7 (8) 21.8 (27) 15.3 (19) 18.5 (23) 13.7 (17) 30.7 (38)
Shockwave 15.4 (21) 26.5 (104) 8.1 (11) 10.8 (8) 8.1 (6) 2.7 (2) 9.5 (7) 68.9 (51)
Shortwave diathermy 43.6 (61) 52.1 (73) 4.3 (6) 21.9 (23) 11.5 (12) 1.9 (2) 17.1 (18) 47.6 (50)
TENS 96.5 (138) 2.8 (4) 0.7 (1) 47.8 (66) 21.7 (30) 11.6 (16) 7.3 (10) 11.6 (16)
Ultrasound 92.3 (132) 5.6 (8) 2.1 (3) 38.0 (52) 21.9 (30) 4.4 (6) 16.0 (22) 19.7 (27)
Whirlpool bath 68.6 (96) 28.6 (40) 2.8 (4) 26.1 (30) 19.1 (22) 9.6 (11) 13.0 (15) 32.2 (37)
EPAs- Electro-physical agents, TENS- Transcutaneous electrical stimulation, IFC- Interferential current, NMES- Neuromuscular electrical stimulation, FES- Functional
electrical stimulation.
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evidence as strong or very strong factors that influence
their decision to use EPA. Although 94.3% of the partici-
pants considered patient preference at least to some extent,
only 37.8% of the participants reported patient preferences
as a strong or very strong factor. Previous studies haveTable 3 Factors that influence the decision to use EPAs
Factors Level
None
1. Background and experience
Entry level (undergraduate) studies & training background 3.6 (5)
Continuing education studies & training 13.2 (1
Previous clinical experience with EPSs 1.4 (2)
Demonstration and exposure to new equipment by medical
marketers
21.6 (3
2. Research evidence for efficacy 5 (7)
3. Technology-related issues
“Technophobia” 61 (86
Fear of adverse events 30.5 (4
4. Availability of equipment 4.3 (6)
5. Operation issues
Time and ease of application 12.8 (1
Degree of self-confidence operating the device 9.2 (13
Busy and tight schedule at workplace 14.2 (2
6. Preferences
Patient preference/request 5.7 (8)
Instruction prescribed by referred physician 38.3 (5
*The results of Chi-Square Test for Equal Proportions for all the factors were p < 0.0identified a low level of shared decision-making between
patients and PTs [10,21], demonstrating the need to
reinforce the patient’s role in the decision-making process.
Though in the current study ‘patient preference’ had the
lowest level of impact on decision making (ranked 3), it
should be noted, however, that not accepting the patient’sof influence: percentage (frequency) Rank
score*
(1) Some (2) Medium (3) Strong (4) Very strong (5)
2
8.6 (12) 28.8 (40) 44.6 (62) 14.4 (20)
8) 11.1 (15) 22.8 (31) 39.7 (54) 13.2 (18)
2.9 (4) 15.1 (21) 49.7 (69) 30.9 (43)
0) 27.3 (38) 36 (50) 12.9 (18) 2.2 (3)
8.5 (12) 31.9 (45) 39.7 (56) 14.9 (21) 2
3
) 17 (24) 14.9 (21) 5 (7) 2.1 (3)
3) 35.5 (50) 18.4 (26) 12.8 (18) 2.8 (4)
5 (7) 25.7 (36) 35 (49) 30 (42) 1
2
8 ) 18.4 (26) 32.6 (46) 29.8 (42) 6.4 (9)
) 10.6 (15) 17.7 (25) 44.7 (63) 17.8 (25)
0) 20.6 (29) 32.6 (46) 22 (31) 10.6 (15)
3
23.6 (33) 32.9 (46) 29.3 (41) 8.5 (12)
4) 32.6 (46) 20.6 (29) 6.4 (9) 2.1 (3)
1.
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not shared. For example, while a patient may request a spe-
cific modality on the basis of information obtained through
an advertisement, the decision not to apply this specific
modality may be still a shared decision following input re-
ceived from the clinician. Nevertheless, due to the important
role of shared decision making, and the unique and import-
ant skills it requires, training for shared decision making
should be incorporated in the training of PTs. It should be
noted that several medical schools, in Israel and around the
world, have begun to take steps in this direction [22].
While, the availability of equipment has been acknowl-
edged as an important factor considered when using EPAs
[12], the category ‘availability of equipment’ was ranked in
the present study as the most influential one. In should be
noted, that while the factors were listed in the question-
naire as independent factors, there was no directive indi-
cating the responders to consider each factors separately
disregarding availability of equipment, thus, probably in-
creasing the significance of the ‘availability of equipment’
factor. Yet, still the fact that equipment availability was
ranked the highest was surprising. Although not directly
investigated in this study, it is likely that when the PTs
considered availability of EPAs, they did not only refer to
whether EPA equipment is present in the clinic, but also
to the degree to which it is available for their use when
needed. For example, while an US device may be present
in the clinic, due to multiple users and a tight schedule
(operational issues), the therapist might have considered it
as not sufficiently available.
The impact of equipment availability on the decision-
making process is concerning. It may indicate that under
some circumstances, such as busy schedules at the work-
place, PTs may not use EPAs even if there is a clinical ra-
tionale for this intervention. It should be noted that a
similar trend was reported in a recent study that tested the
compliance of PTs with a clinical practice guideline for the
treatment of low back pain developed by the National Insti-
tute for Clinical Excellence. The PTs strongly believed in
the principles of the guideline, and thought them relevant
to their practice. Yet, they mentioned that the guideline’s
recommendations were not realistic in day-to-day practice
and therefore were not always adopted [23].
In the present study, the impact of the ‘background and
experience’ category was ranked second after ‘availability of
equipment’. Within this category, previous experience was
considered more influential than any of the other three
factors (entry level education, continuing education and
demonstrations of new equipment). Despite the wide-
spread use of EPAs within physiotherapy practice, previous
studies indicate that EPAs are often poorly understood
[11]. A review by Shah and Farrow [14] intended to describe
EPAs usage from 1990 to 2010 suggested that lack of know-
ledge and training may be a common reason for reduceduse of EPA modalities. Furthermore, a recently published
study found that new physiotherapy graduates may feel not
confident in selecting and using EPAs on entering the work-
force [24]. The findings which reflect that previous experi-
ence was considered more influential than educational
factors, and that only 43.1% of the participants reported
having taken a post-graduate course regarding EPAs usage,
may encourage clinicians to consider to enhance their
knowledge regarding EPAs.
The present study has several limitations. It included a
relatively small convenience sample of therapists who
attended the Israeli Physical Therapy Society Annual Con-
ference which may have introduced a selection bias, as
therapists attending a conference may not necessarily rep-
resent all therapists in the population. A recent report by
the Israeli Ministry of Health has shown that most of the
PTs in Israel are between the ages of 31–44 [25]. It should
be noted that the age distribution in the present sample is
consistent with this report. As with all surveys there might
be additional potential selection bias, as those with strongly
negative or positive views may have been more likely to
participate. However, this bias seems unlikely as the
participants’ responses were varied and presented different
approaches towards the consideration for using EPAs. Fur-
thermore, some participants did not answer all questions,
and the study did not include separate analyses based on
area of practice and seniority .Future studies with larger
samples should be conducted to evaluate whether back-
ground variables effect clinical decision making regarding
use of EPAs. Finally, this study did not refer separately to
each modality. It is neither possible nor appropriate to
draw conclusions regarding decision making for all EPAs
as a group. Thus, additional research that focuses on
specific EPAs is suggested.Conclusions
Decision making regarding the use of EPAs was found
to be multi-dimensional Availability of equipment was
ranked by the participants as the most influential cat-
egory effecting the decision to use EPAs, with the impact
of ‘background and experience’ , ‘research evidence of
efficacy’ , and ‘operational issues’ ranked at a somewhat
lower level. The study offers a framework for PTs to
evaluate their decision making process regarding the ap-
plication of EPAs, which may enhance the quality of care
provided to their patients. In addition, due to the strong
impact of availability of equipment, health policy makers
should verify that the available equipment is up to date
with the best research evidence.Abbreviations
EPAs: Electro-physical agents; PTs: Physiotherapists; US: Ultrasound;
TENS: Transcutaneous electrical nerve stimulation; IFC: Interferential current.
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